transitioning from semaglutide to tirzepatide dosing What's been your experience as a patient or a clinician switching from semaglutide to tirzepatide

Consider whether you'd be prepared to transition to FDA-approved versions or discontinue if compounded access becomes limited

Not for human or animal use, consumption, diagnosis, treatment, food, supplement, cosmetic, veterinary, or similar end use

Concerns include pancreatitis and gallstone formation, which may be associated with significant or rapid weight changes during treatment

Brand pens list windows like 56 or 28 days, but compounded vials differ

The safest approach depends on your current dose, side effect history, and how long youve been on the first medication

Injecting bacteriostatic water directly onto the powder